PCK 2.78% 3.7¢ painchek ltd

Spot on Schmoove, PCK have locked out any future competitors in...

  1. 1,474 Posts.
    lightbulb Created with Sketch. 140
    Spot on Schmoove, PCK have locked out any future competitors in this space, as they did with Nviso early on.
    PD has global medical roll out experience, locking out potential competitors and locking in suppliers such as Nviso is key for steady global expansion. Another top move by co
 
watchlist Created with Sketch. Add PCK (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.